As of January 2025, Nectar Lifesciences has a market cap of $105.71M. This makes Nectar Lifesciences the world's 19458th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $96.78M | 14.31% |
2023 | $84.67M | 30.96% |
2022 | $64.65M | -8.40% |
2021 | $70.58M | 12.13% |
2020 | $62.94M | 96.71% |
2019 | $32.00M | -41.16% |
2018 | $54.38M | -46.98% |
2017 | $102.58M | 18.03% |
2016 | $86.91M | -39.06% |
2015 | $142.61M | 54.27% |
2014 | $92.44M | 88.71% |
2013 | $48.98M | -11.43% |
2012 | $55.31M | 26.89% |
2011 | $43.59M | -46.96% |
2010 | $82.17M | -4.15% |
2009 | $85.72M | 74.53% |
2008 | $49.12M | -37.72% |
2007 | $78.86M | 84.96% |
2006 | $42.64M | -25.27% |
2005 | $57.06M | - |